Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Barbara A Blodi

Showing results (1-10 of 87) with videos related to

Pageof 9
Sort By:
Insight (American Society of Ophthalmic Registered Nurses)|April 14, 2004
Nutritional supplements in the prevention of age-related macular degenerationBarbara A Blodi
American Journal of Ophthalmology|May 31, 2002
Use of the multifocal electroretinogram in the evaluation of a patient with central areolar choroidal dystrophyKristen L Hartley, Barbara A Blodi, James N VerHoeve
Ophthalmology|July 14, 2007
Angiographic and optical coherence tomographic results of the MARINA study of ranibizumab in neovascular age-related macular degenerationPeter K Kaiser, Barbara A Blodi, Howard Shapiro, et al.
Ophthalmic Surgery, Lasers & Imaging : the Official Journal of the International Society for Imaging in the Eye|December 13, 2006
Optical coherence tomography findings in central retinal artery occlusionSuzanne M Falkenberry, Michael S Ip, Barbara A Blodi, et al.
American Journal of Ophthalmology|April 24, 2022
Month 60 Outcomes After Treatment Initiation With Anti-Vascular Endothelial Growth Factor Therapy for Macular Edema Due to Central Retinal or Hemiretinal Vein OcclusionIngrid U Scott, Paul C VanVeldhuisen, Neal L Oden, et al.
American Journal of Ophthalmology|December 7, 2023
Month 60 Imaging Findings and Relationship to Treatment Outcomes Following Anti-VEGF Therapy for Macular Edema Due to Central or Hemi-Retinal Vein OcclusionMichael S Ip, Ingrid U Scott, Paul C VanVeldhuisen, et al.
Graefe'S Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Fur Klinische Und Experimentelle Ophthalmologie|November 29, 2021
SCORE2 Report 17: Macular thickness fluctuations in anti-VEGF-treated patients with central or hemiretinal vein occlusionIngrid U Scott, Neal L Oden, Paul C VanVeldhuisen, et al.
JAMA Ophthalmology|March 24, 2022
Baseline Characteristics and Outcomes After Anti-Vascular Endothelial Growth Factor Therapy for Macular Edema in Participants With Hemiretinal Vein Occlusion Compared With Participants With Central Retinal Vein Occlusion: Study of Comparative Treatments for Retinal Vein Occlusion 2 (SCORE2) Report 18Ingrid U Scott, Neal L Oden, Paul C VanVeldhuisen, et al.
Ophthalmology|May 23, 2023
SCORE2 Report 24: Nonlinear Relationship of Retinal Thickness and Visual Acuity in Central Retinal and Hemiretinal Vein OcclusionIngrid U Scott, Neal L Oden, Paul C VanVeldhuisen, et al.
American Journal of Ophthalmology|May 5, 2024
Association of Retinal Thickness at Month 1 Postrandomization With Later Thickness and Visual Acuity in Central Vein OcclusionIngrid U Scott, Neal L Oden, Michael S Ip, et al.
Pageof 9

Showing results (1-10 of 87) with videos related to

Sort By:
Pageof 9
Insight (American Society of Ophthalmic Registered Nurses)|April 14, 2004
Nutritional supplements in the prevention of age-related macular degenerationBarbara A Blodi
American Journal of Ophthalmology|May 31, 2002
Use of the multifocal electroretinogram in the evaluation of a patient with central areolar choroidal dystrophyKristen L Hartley, Barbara A Blodi, James N VerHoeve
Ophthalmology|July 14, 2007
Angiographic and optical coherence tomographic results of the MARINA study of ranibizumab in neovascular age-related macular degenerationPeter K Kaiser, Barbara A Blodi, Howard Shapiro, et al.
Ophthalmic Surgery, Lasers & Imaging : the Official Journal of the International Society for Imaging in the Eye|December 13, 2006
Optical coherence tomography findings in central retinal artery occlusionSuzanne M Falkenberry, Michael S Ip, Barbara A Blodi, et al.
American Journal of Ophthalmology|April 24, 2022
Month 60 Outcomes After Treatment Initiation With Anti-Vascular Endothelial Growth Factor Therapy for Macular Edema Due to Central Retinal or Hemiretinal Vein OcclusionIngrid U Scott, Paul C VanVeldhuisen, Neal L Oden, et al.
American Journal of Ophthalmology|December 7, 2023
Month 60 Imaging Findings and Relationship to Treatment Outcomes Following Anti-VEGF Therapy for Macular Edema Due to Central or Hemi-Retinal Vein OcclusionMichael S Ip, Ingrid U Scott, Paul C VanVeldhuisen, et al.
Graefe'S Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Fur Klinische Und Experimentelle Ophthalmologie|November 29, 2021
SCORE2 Report 17: Macular thickness fluctuations in anti-VEGF-treated patients with central or hemiretinal vein occlusionIngrid U Scott, Neal L Oden, Paul C VanVeldhuisen, et al.
JAMA Ophthalmology|March 24, 2022
Baseline Characteristics and Outcomes After Anti-Vascular Endothelial Growth Factor Therapy for Macular Edema in Participants With Hemiretinal Vein Occlusion Compared With Participants With Central Retinal Vein Occlusion: Study of Comparative Treatments for Retinal Vein Occlusion 2 (SCORE2) Report 18Ingrid U Scott, Neal L Oden, Paul C VanVeldhuisen, et al.
Ophthalmology|May 23, 2023
SCORE2 Report 24: Nonlinear Relationship of Retinal Thickness and Visual Acuity in Central Retinal and Hemiretinal Vein OcclusionIngrid U Scott, Neal L Oden, Paul C VanVeldhuisen, et al.
American Journal of Ophthalmology|May 5, 2024
Association of Retinal Thickness at Month 1 Postrandomization With Later Thickness and Visual Acuity in Central Vein OcclusionIngrid U Scott, Neal L Oden, Michael S Ip, et al.
Pageof 9